Director John W. Higuchi filed a Form 4 with the SEC on November 20, 2026, disclosing two open-market purchases of Lipocine Inc. common stock totaling 150,000 shares on November 19 and November 20, 2026.
Key Highlights
- First purchase: 75,000 shares of common stock acquired on November 19, 2026, at $1.5119 per share.
- Second purchase: 75,000 shares of common stock acquired on November 20, 2026, at $1.4911 per share.
- Beneficial ownership after transactions: 391,365 shares held directly following the second purchase.
- Reporting person: John W. Higuchi, identified as a director of Lipocine Inc. (NASDAQ:LPCN).
- Both transactions are coded "P" (open-market purchase) and listed as directly owned.
Higuchi's Two-Day Purchase of Lipocine Common Stock
According to the filing, John W. Higuchi, a director of Lipocine Inc. (NASDAQ:LPCN), reported two separate acquisitions of the company's common stock on consecutive trading days. On November 19, 2026, Higuchi acquired 75,000 shares at a price of $1.5119 per share, bringing his directly held beneficial ownership to 316,365 shares following that transaction, the filing disclosed.
The following day, November 20, 2026, Higuchi acquired an additional 75,000 shares at $1.4911 per share, according to the filing. After this second purchase, his total directly held beneficial ownership stood at 391,365 shares, as reported in Table I of the Form 4. Both transactions are classified with transaction code "P," indicating open-market purchases, and both are recorded with a deemed execution date matching the transaction date.
The filing was signed by John W. Higuchi on November 20, 2026. No derivative securities transactions were reported in Table II of the filing. The form identifies Higuchi's address as c/o 675 Arapeen Dr., Suite 202, Salt Lake City, Utah 84108, and confirms the filing was made by one reporting person.
What Was Disclosed
Lipocine Inc. director John W. Higuchi disclosed the purchase of 150,000 shares of common stock across two transactions on November 19 and November 20, 2026, at prices of $1.5119 and $1.4911 per share, respectively, resulting in directly held beneficial ownership of 391,365 shares.


Please wait processing your request...